Full-Time

Oncology Clinical Navigator

Triomics

Triomics

51-200 employees

EHR data parsing with oncology LLMs

Compensation Overview

$80k - $130k/yr

New York, NY, USA

Hybrid

Hybrid office work and travel to customer sites are required.

Bachelor's

Category
Customer Experience & Support (2)
,
Required Skills
LLM
Electronic Health Records (EHR)

Get referred to Triomics

See people who can refer or advise you

Requirements
  • Two to four years of experience as an oncology nurse, clinical research coordinator, or in a similar oncology clinical or clinical-research role.
  • First-hand experience working in oncology care and/or clinical research at a cancer center or comparable setting.
  • Strong understanding of oncology, including how cancer is treated from diagnosis through treatment and recovery, and fluency in cancer terminology.
  • Demonstrated ability to teach, train, or onboard clinical peers and drive adoption of new tools or workflows.
  • Strong communication skills and the credibility to influence physicians, nurses, and clinical research coordinators.
  • Strong technology skills and comfort working with modern software platforms.
  • Based in New York City and willing to come to the office and travel to customer sites, or based in a regional customer hub and willing to travel to assigned accounts and New York City periodically.
Responsibilities
  • Design and deliver training for clinical end users of the Triomics platform, including physicians, nurses, and clinical research coordinators, tailored to their workflows and technology comfort levels.
  • Build scalable, reusable enablement assets such as onboarding tracks, quick-reference guides, workflow walkthroughs, and release-update training.
  • Serve as the clinical adoption partner at assigned accounts and build user confidence in new workflows.
  • Embed with clinical and research teams at assigned cancer centers to understand their workflows, pain points, and goals.
  • Devise and implement account-specific adoption plans by identifying champions, sequencing rollout, and supporting users through change.
  • Act as a peer and translator between clinical end users and Triomics.
  • Provide hands-on, high-touch support through go-live and steady-state usage.
  • Partner with Account Managers as the clinical adoption arm of the customer relationship and keep them informed about user sentiment, adoption blockers, and opportunities.
  • Surface customer-specific needs to Forward Deployed Engineers so the artificial intelligence pipeline and platform can be adjusted for each account.
  • Flag recurring user friction and feature requests to Product and Engineering as structured, prioritized feedback.
  • Provide feedback on the platform's user interface and capabilities to maximize clinician usability and institutional goals.
  • Help build repeatable training and adoption playbooks for scaling the customer delivery model.
  • Continuously refine how adoption is measured and improved across accounts.
Desired Qualifications
  • Experience specifically in clinical research operations, including trial conduct, inclusion/exclusion criteria, patient recruitment, and data abstraction.
  • Experience as a super-user, trainer, or change champion for an electronic health record or other clinical software implementation.
  • Experience at a high-growth health technology company or supporting deeply integrated or technical products in a clinical setting.
  • Bachelor's degree or higher in a relevant field.
  • Familiarity with oncology clinical trial workflows and the cancer center research ecosystem.

Triomics uses generative AI to turn unstructured health-record data in oncology into actionable insights. Its OncoLLM analyzes doctor notes, PDFs, and lab results to extract relevant clinical information, with Prism automating patient-to-clinical-trial matching and Harmony curating EHR data for quality reporting and cohort analysis. By integrating with existing EHR systems, it speeds up tasks that used to require hours of manual review and can match patients to trials in minutes with high accuracy. The goal is to reduce manual data review in cancer research and care, accelerate trial enrollment, and support precision oncology for cancer centers, academic medical centers, and health systems.

Company Size

51-200

Company Stage

Series B

Total Funding

$54.2M

Headquarters

New York City, New York

Founded

2020

Get referred to Triomics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Triomics raised $22 million in May 2026, bringing total funding above $36 million.
  • May 2026 reports say customers grew fourfold and annualized recurring revenue rose tenfold.
  • January 2026 Mount Sinai and October 2025 MSK deployments prove enterprise adoption momentum.

What critics are saying

  • Epic and Flatiron can bundle oncology workflow features and squeeze Triomics by 2027.
  • Model errors in trial matching trigger missed enrollments, compliance failures, and clinician distrust immediately.
  • If Battery's $22 million Series B fails to convert into durable ARR, Triomics stalls.

What makes Triomics unique

  • Triomics sells oncology-specific AI, not generic chart summarization, with source-backed outputs.
  • Its platform embeds trial matching, pre-charting, and registry abstraction inside clinician workflows.
  • MSK, MD Anderson, Yale, and Mount Sinai validate its oncology-specialized workflow moat.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Flexible Work Hours

Meal Benefits

Growth & Insights and Company News

Headcount

6 month growth

-6%

1 year growth

-9%

2 year growth

-10%
TechCrunch
May 27th, 2026
Triomics nabs $22M to bring oncology-specific AI to cancer centers | TechCrunch

The Series B round was led by Battery Ventures.

SVJ Media Ltd.
May 10th, 2024
Triomics Raises $15M for AI Trials

Triomics, a generative AI startup, has secured $15M in Series A funding to enhance cancer clinical trials matching. Founded by Sarim Khan and Hrituraj Singh, the company's OncoLLM platform uses AI to quickly match patients with trials, improving efficiency in cancer care. With this funding from Lightspeed, Nexus Venture Partners, General Catalyst, and Y Combinator, Triomics plans to expand its reach and develop its platform further.

TechCrunch
May 9th, 2024
Triomics raises $15M Series A to automate cancer clinical trials matching | TechCrunch

For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each

Intelligence360 News
Mar 6th, 2023
Triomics Has Filed A Notice Of An Exempt Offering Of Securities To Raise $14,135,000.00 In New Equity Investment.

Triomics has filed a notice of an exempt offering of securities to raise $14,135,000.00 in New Equity Investment. Triomics has filed a notice of an exempt offering of securities to raise $14,135,000.00 in New Equity Investment.According to filings with the U.S. Securities and Exchange Commission, Triomics is raising $14,135,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Sarim Khan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.About TriomicsTriomics combines the most advanced clinical trial tracking software with a global network of supersites and partners to deliver rapid, cost-effective, high quality clinical trials that pass even the most rigorous regulatory scrutiny. Triomics Harmony© is powering a host of next-generation applications of healthcare data and systems for advancing clinical research by harnessing the growing maturity of US healthcare on FHIR and addressing its current limitations, enabling us to empower healthcare organizations at any phase of their FHIR adoption journey.To learn more about Triomics, visit http://www.triomics.in/Contact:Sarim Khan, Chief Executive Officer707-227-9112https://www.linkedin.com/in/sarim-khan-triomics/SOURCE: http://www.intelligence360.ioCopyright (c) 2023 SI360 Inc. All rights reserved